|
Real-time Estimate
Cboe BZX
18:25:21 10/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 252.92 USD | +0.80% |
|
-3.14% | +10.31% |
| 05:54pm | AbbVie's Menstrual Migraine Treatment Meets Primary, Secondary Endpoints in Phase 3 Trial | DJ |
| 05:41pm | AbbVie's menstrual migraine treatment meets late-stage study goal | RE |
| Market Cap | 443B 382B 359B 327B 612B 42,191B 615B 4,258B 1,646B 21,494B 1,665B 1,629B 68,094B | P/E 2026 * |
32.1x | P/E 2027 * | 23.9x |
|---|---|---|---|---|---|
| Enterprise Value | 504B 434B 408B 372B 696B 47,947B 699B 4,839B 1,870B 24,427B 1,892B 1,851B 77,384B | EV / Sales 2026 * |
7.46x | EV / Sales 2027 * | 6.73x |
| Free-Float |
95.71% | Yield 2026 * |
2.73% | Yield 2027 * | 2.87% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABBV | Delayed | |
CBOE
| ABBV | Real-time | |
|
Tradegate
| 4AB | Real-time | |
|
Boerse Muenchen
| 4AB | Real-time | |
|
Mexican S.E.
| ABBV * | End-of-day quote | |
|
London S.E.
| 0QCV | Delayed | |
|
Deutsche Boerse AG
| 4AB | Delayed | |
|
CBOE
| Real-time | ||
|
Xetra
| 4AB | Delayed | |
|
Swiss Exchange
| ABBV | Delayed | |
|
Wiener Boerse
| ABBV | End-of-day quote | |
|
Börse Stuttgart
| 4AB | Delayed | |
|
Borsa Italiana
| 1ABBV | End-of-day quote | |
|
CBOE
| 0QCV | Real-time | |
|
Santiago S.E.
| ABBV | End-of-day quote | |
|
Santiago S.E.
| ABBVCL | End-of-day quote | |
|
Swiss Exchange
| ABBV | Delayed |
Last Transcript : AbbVie Inc.
| 1 day | +0.68% | ||
| 1 week | -3.14% | ||
| Current month | -1.70% | ||
| 1 month | +1.65% | ||
| 3 months | +12.05% | ||
| 6 months | +11.03% | ||
| Current year | +10.31% |
| 1 week | 246.77 |  | 258.91 |
| 1 month | 245.52 | | 266.96 |
| Current year | 190.75 | | 267.47 |
| 1 year | 190.75 | | 267.47 |
| 3 years | 135.85 | | 267.47 |
| 5 years | 105.56 | | 267.47 |
| 10 years | 55.06 | | 267.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/26 | Exercice | Executive/Senior Manager | 98,130 | 0.0056% | ||
| 30/06/26 | Free | Director | 62 | 0.0000% | ||
| 30/06/26 | Free | Director | 134 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -3.14% | +19.09% | +69.12% | 443B | |
| +0.59% | -3.01% | +49.05% | +88.85% | 1,002B | |
| +0.12% | -4.12% | +51.86% | +64.12% | 644B | |
| +0.03% | -3.14% | +29.76% | +36.00% | 343B | |
| +1.33% | -14.59% | +11.34% | +27.01% | 262B | |
| +1.26% | -3.64% | -1.76% | +11.45% | 245B | |
| -0.82% | -12.60% | +39.38% | +48.32% | 212B | |
| -0.26% | -4.92% | -18.35% | -58.08% | 199B | |
| -0.60% | -4.45% | +25.37% | +87.55% | 181B | |
| -0.77% | -4.36% | +12.15% | -18.81% | 158B | |
| Average | +0.07% | -4.92% | +21.79% | +35.55% | 368.8B | |
| Weighted average by Cap. | +0.24% | -4.24% | +31.16% | +52.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.58B 58.16B 54.76B 49.9B 93.35B 6,431B 93.73B 649B 251B 3,276B 254B 248B 10,379B | 73.52B 63.26B 59.57B 54.28B 102B 6,996B 102B 706B 273B 3,564B 276B 270B 11,291B |
| Net income | 13.86B 11.93B 11.23B 10.23B 19.15B 1,319B 19.22B 133B 51.45B 672B 52.05B 50.92B 2,129B | 18.91B 16.28B 15.32B 13.96B 26.13B 1,800B 26.23B 182B 70.2B 917B 71.02B 69.48B 2,905B |
| Net Debt | 60.49B 52.05B 49.01B 44.66B 83.56B 5,756B 83.89B 581B 225B 2,932B 227B 222B 9,290B | 51.66B 44.45B 41.86B 38.14B 71.36B 4,916B 71.64B 496B 192B 2,504B 194B 190B 7,934B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | $251.83 | +0.36% | 400,352 |
| 09/09/26 | $250.91 | +0.86% | 3,866,951 |
| 08/09/26 | $248.78 | -2.99% | 5,572,102 |
| 04/09/26 | $256.46 | -1.44% | 4,729,800 |
| 03/09/26 | $260.21 | -0.58% | 2,878,739 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
